Rosuvastatin Calcium Tablet, Film Coated
Product Images NDC 68462-263

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Rosuvastatin Calcium (NDC 68462-263). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Glenmark Pharmaceutials Inc., Usa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Structure)

Chemical structure of Rosuvastatin calcium, showing its molecular arrangement including a fluorophenyl group, sulfonyl methyl, hydroxyl groups, and calcium ion complexation.*

FDA Label Image

Figure1 (Figure1)

A line chart comparing cumulative incidence percentages over years for Rosuvastatin calcium (labeled as Rosuva) versus placebo. The graph shows a lower cumulative incidence for Rosuvastatin calcium compared to placebo across a 5-year period. Hazard ratio (HR) and confidence interval (CI) values are displayed, along with a P value below 0.001. Numbers at risk for Rosuvastatin calcium and placebo groups are listed below the x-axis by year.*

FDA Label Image

Figure2 (Figure2)

Data table presenting the number of cardiovascular-related events for Rosuvastatin calcium 20 mg versus placebo in a clinical study. It includes event counts, rates per 1000 patient years, hazard ratios with 95% confidence intervals, and p-values for primary endpoint, cardiovascular death, nonfatal stroke, nonfatal myocardial infarction, hospitalized unstable angina, and arterial revascularization, accompanied by a graphical hazard ratio plot.*

FDA Label Image

Figure3 (Figure3)

Box plot chart showing percent change from baseline in LDL-C levels for four statin drugs—Rosuvastatin, Atorvastatin, Simvastatin, and Pravastatin—across different dose strengths (mg). The y-axis represents percent change, and individual dose values are labeled on top for each drug.*

FDA Label Image

Logo1 (Logo1)

FDA Label Image

Logo2 (Logo2)

FDA Label Image

Lbl5mg90s (Lbl5mg90s)

Rosuvastatin Tablets USP 5 mg film-coated tablets carton label by Glenmark Pharmaceuticals Inc., USA. Contains 90 tablets, Rx only. Label instructs storage at controlled room temperature and provides distributor contact information along with barcode and NDC details.*

FDA Label Image

Lbl10mg90s (Lbl10mg90s)

Label for Rosuvastatin Tablets, USP 10 mg film-coated tablets. The label shows the product name, strength, and dosage form, along with the Glenmark logo and labeler information: Glenmark Pharmaceuticals Inc., USA. It indicates a package of 90 tablets, includes storage instructions, and contact information for questions.*

FDA Label Image

Lbl20mg90s (Lbl20mg90s)

Label for Rosuvastatin Tablets USP 20 mg film-coated tablets manufactured by Glenmark Pharmaceuticals Inc., USA. The label states the product is for oral use, prescription only, and contains 90 tablets per package. It includes NDC 68462-263-90 and a barcode.*

FDA Label Image

Lbl40mg30s (Lbl40mg30s)

Rosuvastatin Tablets USP 40 mg film-coated tablets packaging label by Glenmark Pharmaceuticals Inc., USA. The label states a blister pack containing 30 tablets for oral use. It includes storage instructions, manufacturing details, and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.